文献速递腹部泌尿生殖MR

化学位移MRI显示不均匀微观脂肪的肾上腺结节恶性患病率:多中心研究

Prevalence of Malignancy in Adrenal Nodules With Heterogeneous Microscopic Fat on Chemical-Shift MRI: A Multiinstitutional Study.
PubMed 文献 · AJR Am J Roentgenol · 2022-08-03

多中心回顾性研究纳入282例患者共283个肾上腺结节,评估双回波T1加权化学位移MRI上不均匀微观脂肪(信号丢失面积<80%)的恶性患病率。无既往癌症患者中无恶性结节(0/197);有既往癌症患者中4.7%(4/86)为转移瘤。结论认为不均匀微观脂肪提示良性可能性高,尤其无癌症史者,但既往癌症患者需谨慎。

要点

  • 无既往癌症史者,肾上腺结节伴不均匀微观脂肪无需额外影像评估。
  • 有既往癌症史者,4.7%为转移瘤,需结合原发肿瘤是否含脂及信号丢失形态谨慎判断。
  • 信号丢失模式包括弥漫性、斑点状、两部分、中心性及周边性,转移瘤可表现为任一模式。

关键影像表现/征象

  • 信号丢失模式分布:弥漫性不均匀40%(114/283)、斑点状28%(80/283)、两部分18%(51/283)、中心性9%(26/283)、周边性4%(12/283)。
  • 肝细胞癌和肾细胞癌转移表现为弥漫性不均匀信号丢失;肺癌转移表现为两部分模式;结肠癌合并肾细胞癌转移表现为周边信号丢失。
  • 结节平均长轴直径18.7±7.9 mm(范围10-80 mm)。

诊断标准与关键数值

  • 不均匀微观脂肪定义为反相位化学位移MRI上信号丢失面积<80%。
  • 无既往癌症患者恶性结节患病率0/197(95%CI 0-1.5%)。
  • 有既往癌症患者恶性结节患病率4.7%(4/86,95%CI 1.3-11.5%)。

临床应用与阅片要点

  • 无癌症史患者发现肾上腺结节伴不均匀微观脂肪时,可避免额外影像检查。
  • 有癌症史患者需结合原发肿瘤是否可能含脂(如HCC、RCC)及信号丢失形态(弥漫、斑点、两部分、中心、周边)综合判断,警惕碰撞瘤。

局限性

  • 回顾性研究设计。
  • 参考标准不统一,部分结节仅基于影像或临床随访。
  • 有既往癌症患者样本量较小(86例),转移瘤例数少(4例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Homogeneous microscopic fat within adrenal nodules on chemical-shift MRI (CS-MRI) is diagnostic of benign adrenal adenoma, but the clinical relevance of heterogeneous microscopic fat is not well established. OBJECTIVE. This study sought to determine the prevalence of malignancy in adrenal nodules with heterogeneous microscopic fat on dual-echo T1-weighted CS-MRI. METHODS. We performed a retrospective study of adult patients with adrenal nodules detected on MRI performed between August 2007 and November 2020 at seven institutions. Eligible nodules had a short-axis diameter of 10 mm or larger with heterogeneous microscopic fat (defined by an area of signal loss of < 80% on opposed-phase CS-MRI). Two radiologists from each center, blinded to reference standard results, determined the signal loss pattern (diffuse, two distinct parts, speckling pattern, central loss, or peripheral loss) within the nodules. The reference standard used was available for 283 nodules (pathology for 21 nodules, ≥ 1 year of imaging follow-up for 245, and ≥ 5 years of clinical follow-up for 17) in 282 patients (171 women and 111 men; mean age, 60 ± 12 [SD] years); 30% (86/282) patients had prior malignancy. RESULTS. The mean long-axis diameter was 18.7 ± 7.9 mm (range, 10-80 mm). No malignant nodules were found in patients without prior cancer (0/197; 95% CI, 0-1.5%). Four of the 86 patients with prior malignancy (hepatocellular carcinoma [HCC], renal cell carcinoma [RCC], lung cancer, or both colon cancer and RCC) (4.7%; 95% CI, 1.3-11.5%) had metastatic nodules. Detected patterns were diffuse heterogeneous signal loss (40% [114/283]), speckling (28% [80/283]), two distinct parts (18% [51/283]), central loss (9% [26/283]), and peripheral loss (4% [12/283]). Two metastases from HCC and RCC showed diffuse heterogeneous signal loss. Lung cancer metastasis manifested as two distinct parts, and the metastasis in the patient with both colon cancer and RCC showed peripheral signal loss. CONCLUSION. Presence of heterogeneous microscopic fat in adrenal nodules on CS-MRI indicates a high likelihood of benignancy, particularly in patients without prior cancer. This finding is also commonly benign in patients with cancer; however, caution is warranted when primary malignancies may contain fat or if the morphologic pattern of signal loss may indicate a collision tumor. CLINICAL IMPACT. In the absence of prior cancer, adrenal nodules with heterogeneous microscopic fat do not require additional imaging evaluation.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Taffel, Petrocelli, Rigau, et al. Prevalence of Malignancy in Adrenal Nodules With Heterogeneous Microscopic Fat on Chemical-Shift MRI: A Multiinstitutional Study. AJR Am J Roentgenol. 2022. PMID: 35920707. doi:10.2214/AJR.22.27976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。